参考文献/References:
[1] 钱会南.《黄帝内经》十三方的后世临床运用启示[J].安徽中医药大学学报, 2023, 42(3):1-4.
[2] Fang S, Dong L, Liu L, et al.HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine[J].Nucleic Acids Res, 2021, 49(D1):D1197-D1206.
[3] Gfeller D, Grosdidier A, Wirth M, et al.Swiss target prediction: a web server for target prediction of bioactive small molecules[J].Nucleic Acids Res, 2014, 42(Web Server issue):W32-38.
[4] Franceschini A, Szklarczyk D, Frankild S, et al.STRING v9.1: protein-protein interaction networks, with increased coverage and integration[J].Nucleic Acids Res, 2013, 41(Database issue):D808-815.
[5] Zhou Y, Zhou B, Pache L, et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J].Nat Commun, 2019, 10(1):1523.
[6] Zhang D Y, Yao X H, Duan M H, et al.An effective homogenate-assisted negative pressure cavitation extraction for the determination of phenolic compounds in pyrola by LC-MS/MS and the evaluation of its antioxidant activity[J].Food Funct, 2015, 6(10):3323-3333.
[7] 高改, 李二稳, 王梦瑶, 等.基于SREBPs的泽泻活性成分及其降脂作用研究[J].时珍国医国药, 2022, 33(3):521-526.
[8] 颜培正, 孟庆岩, 常兴, 等.《黄帝内经》“酒风”病因病机探析[J].中国中医基础医学杂志, 2017, 23(2):149-150,155.
[9] 谢治深, 黄小虹, 袁永, 等.泽泻抑制脂多糖诱导的RAW264.7炎症及作用机制[J].时珍国医国药, 2020, 31(7):1586-1590.
[10] 陈琴华, 余飞, 王红梅, 等.白术内酯Ⅰ、Ⅱ、Ⅲ对炎性巨噬细胞细胞因子表达的影响[J].中国药师, 2017, 20(12):2112-2116.
[11] Chen Y, Yang W, Guo L, et al.Atractylodes lactone compounds inhibit platelet activation[J].Platelets, 2017, 28(2):194-202.
[12] 郭雨雅, 孙晓琦, 方晶, 等.加味泽泻汤对NAFLD大鼠肝脏炎症信号通路相关蛋白表达的影响[J].中国实验方剂学杂志, 2017, 23(5):90-94.
[13] Matsushita T, Sasaki H, Takayama K, et al.The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1β in human chondrocytes[J].J Orthop Res, 2013, 31(4):531-537.